Target intelligence / Profile preview

Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 (DPAGT1)

Target
DPAGT1
Molecular classification
Enzyme, Transferase, Integral membrane protein
01

Overview

Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 (DPAGT1) is an essential enzyme in the process of protein N-glycosylation. It catalyzes the first committed step in the dolichol-linked oligosaccharide pathway, which is crucial for glycoprotein biosynthesis in eukaryotic cells. It transfers N-acetylglucosamine (GlcNAc) from uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) to dolichyl-phosphate, forming dolichyl-phosphate N-acetylglucosamine and UMP. Mutations or dysfunctions in DPAGT1 can result in congenital disorders of glycosylation (CDG), affecting multiple organ systems due to defective protein glycosylation. The best-known inhibitor is tunicamycin, which blocks eukaryotic protein N-glycosylation.

02

Mechanism of action

Inhibition of dolichyl-phosphate N-acetylglucosaminephosphotransferase activity, blocking eukaryotic protein N-glycosylation.

03

Biological functions

Protein N-glycosylationGlycoprotein biosynthesisLipid-linked oligosaccharide synthesis
04

Disease associations

Congenital disorders of glycosylation (CDG)
05

Safety considerations

Inhibition of DPAGT1 can lead to severe defects due to impaired protein glycosylation, as demonstrated in mouse oocytes leading to infertility.
06

Interacting drugs

Tunicamycin

Beyond the preview

Go deeper on Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 (DPAGT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 (DPAGT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call